[Pharmaceutical preparations which contain tartrazine]

Area of Science:

• Food science and toxicology
• Clinical immunology and allergy

Context:

• Allergic reactions to food colorings have been documented since 1958.
• Tartrazine (Yellow No. 5) is a common food dye known to trigger various adverse reactions.
• Cross-reactivity between tartrazine and anti-inflammatory drugs like aspirin is observed in sensitive patients.

Purpose:

• To identify medications potentially containing food dyes, specifically tartrazine.
• To assess the prevalence of food dye use in pharmaceutical products.
• To raise awareness about the risks associated with food dye allergies in medications.

Summary:

• A survey of 233 laboratories revealed that 72 (45%) confirmed the presence of food dyes, including tartrazine, in certain drugs.
• Reactions to tartrazine can range from mild pruritus to severe asthma attacks and purpura, occurring within minutes to hours.
• The study highlights the critical issue of undeclared food dyes in medications, which can be life-threatening for allergic individuals.

Impact:

• Informs healthcare professionals and patients about potential allergens in medications.
• Emphasizes the need for clear labeling of food dyes in pharmaceutical products.
• Contributes to patient safety by reducing the risk of accidental allergic reactions to medications.